BLOODPAC's mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer. To do so, we lead a collaborative infrastructure that enables sharing of information between stakeholders in public, industry, academia and regulatory agencies.
BLOODPAC's mission is to accelerate the development, validation and accessibility of liquid biopsy assays to improve the outcomes of patients with cancer. To do so, we lead a collaborative infrastructure that enables sharing of information between stakeholders in public, industry, academia and regulatory agencies.